Day: March 19, 2021

Galimmo-Document d’Enregistrement Universel 2020Pièce jointeGAL2020_URD_GALIMMO_FR_VMEL_21_03_19

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTIONFOR IMMEDIATE RELEASE19 March 2021G4S PLC (“G4S”)NASDAQ APPROVES G4S’ REQUESTFOR REMOVAL FROM TRADING ON NASDAQ AND OFFICIAL LISTING IN DENMARKNasdaq Copenhagen A/S (“Nasdaq“) has today approved G4S’s request for the removal from trading of its shares from Nasdaq and official listing (together the “Delisting“) pursuant to Supplement A, Rule 22 (ii) of the Nordic Main Market Rulebook (the “Rulebook“).  The last day of trading on Nasdaq will be 16 April 2021.This does not affect G4S’ primary listing on the London Stock Exchange (the “LSE“).Holders of G4S instruments traded on Nasdaq...

The Annual General Meeting of Shareholders of Tallinna Kaubamaja Grupp AS was held on 19 March 2021 at the Radisson Blu Hotel Olümpia Conference Centre at Liivalaia 33, Tallinn. 29,541,042 votes, i.e. 72.53% of the Company`s 40,729,200 votes were represented at the meeting and 54 shareholders were represented at the meeting.The decisions of the General Meeting were as follows:1. Approval of the annual report of Tallinna Kaubamaja Grupp AS for 2020With 29,541,042, i.e. 100% votes in favour, to approve the annual report of Tallinna Kaubamaja Grupp AS for 2020, in accordance with which the consolidated balance sheet of Tallinna Kaubamaja Grupp AS as at 31 December 2020 is 597,284 thousand euros, sales revenue 741,938 thousand euros, and net profit 19,499 thousand euros.2. Profit distributionWith 29,541,042, i.e. 100.00% votes in favour,...

19. märtsil 2021. aastal toimus Tallinna Kaubamaja Grupp AS-i aktsionäride korraline üldkoosolek Tallinnas, aadressil Liivalaia tänav 33 asuvas Radisson Blu Hotel Olümpia konverentsikeskuses. Ettevõtte 40 729 200 häälest oli koosolekul esindatud 29 541 042 häält, so 72,53% kõikidest häältest ning kokku oli esindatud 54 aktsionäri.Tallinna Kaubamaja Grupp AS-i aktsionäride üldkoosolek otsustas:1. Tallinna Kaubamaja Grupp AS 2020. a. majandusaasta aruande kinnitamineKinnitada 29 541 042 hääle ehk 100% poolthäälega Tallinna Kaubamaja Grupp 2020. a majandusaasta aruanne, mille kohaselt Tallinna Kaubamaja Grupp AS konsolideeritud bilansimaht seisuga 31.12.2020 on 597 284 tuhat eurot, aruandeaasta müügitulu 741 938 tuhat eurot ning puhaskasum 19 499 tuhat eurot.2. Kasumi jaotamineKinnitada 29 541 042 hääle ehk 100,00% poolthäälega Tallinna...

COLUMBIA, Md., March 19, 2021 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE: GRA) today commented on the extreme winter weather that impacted Texas and Louisiana in mid-February. Winter Storm Uri was a major storm that caused widespread manufacturing disruption across the region because of freezing temperatures and loss of electricity, gas, water, and other utilities. Most polyolefin manufacturers and refineries in the region were forced to shut down or operate at reduced rates following the storm. Grace operates four manufacturing facilities in the region. All sites experienced interruptions, with extended downtime at three plants ranging from 8 to 24 days. All sites have resumed operations. Most of our customers have restarted operations though many are still operating at reduced rates.“Our immediate focus from the onset of...

RESEARCH TRIANGLE PARK, N.C., March 19, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Helen Thackray, M.D., FAAP, to the newly created position of chief research and development officer.In this role, Dr. Thackray will be responsible for continuing to build the company’s portfolio of rare disease medicines by developing and advancing the company’s R&D strategy from drug discovery through clinical development and regulatory approval.Dr. Thackray currently serves on the BioCryst board of directors and most recently served as chief medical officer and senior vice president of clinical development at GlycoMimetics, Inc. where she led their orphan product, fast track, and breakthrough therapy programs at all stages of development in rare diseases and oncology.Prior...

PORTLAND, Ore., March 19, 2021 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the grand opening of Harts Crossing, a new community in Portland, Ore., located 10 miles east of downtown. This enclave of 32 townhomes offers new, low maintenance homes with included upgrades in a commuter-friendly location near the TriMet MAX light rail. Pricing starts in the $390s.“We are excited to announce our first community located in the heart of Multnomah County,” said Ryan Stokes, division president at LGI Homes. “Harts Crossing gives our customers immediate access to the city of Portland’s many amenities and attractions. Our convenient location within walking distance of the light rail allows residents to experience immediate access to downtown while enjoying the benefits of homeownership.”Buyers may choose from three...

BRIDGEVILLE, Pa., March 19, 2021 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it has amended and restated its five-year $120 million asset-based lending (ABL) credit agreement with PNC Bank, National Association. The new agreement includes a revolving credit facility of $105 million and increases the term loan facility to $15 million. The Company’s obligations under the amended and restated credit agreement continue to be collateralized by substantially all of the Company’s accounts receivables, inventory, and fixed assets. The new credit agreement will expire in March 2026.The amended and restated credit agreement supersedes the Company’s prior ABL credit agreement with PNC Bank, which was scheduled to expire in August 2023.In conjunction with this amendment, the Company...

CHATHAM, N.J., March 19, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,946,027 to the Company on March 16, 2021. Tianeptine oxalate is the active pharmaceutical ingredient of Tonix’s development candidate, TNX-601 CR (tianeptine oxalate and naloxone controlled-release tablet). The new patent, “Tianeptine Oxalate Salts and Polymorphs,” includes claims directed to pharmaceutical compositions comprising crystalline tianeptine oxalate salts, to methods of using those compositions to treat various disorders, and to methods of producing the oxalate salts. This patent is expected to provide Tonix with U.S. market exclusivity until December 28, 2037, excluding...

VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) — Neptune Digital Assets Corp. (TSX-V:NDA) (OTC:NPPTF) (FSE:1NW) (“Neptune” or the “Company“), a cryptocurrency leader in Canada, is pleased to announce that they have signed a letter of intent with Link Global Technologies Inc. (“LINK”) ( CSE:LNK) (FSE:LGT) (OTC:LGLOF) to co-develop a 5MW renewable energy Bitcoin mining facility in Alberta, Canada. This agreement follows shortly after a separate partnership on March 4, 2021 with Link to procure and operate 1500 ASIC mining machines for Neptune at their existing facilities.Key Highlights:The new mining facility is a 50/50 joint venture between LINK and Neptune, sharing equally in both costs and revenues.The location of the site will be in Alberta where LINK operates the majority of their Bitcoin mining facilities.This...